Question 1

How many shares of EFTR does GEODE CAPITAL MANAGEMENT, LLC own?

Accepted Answer

GEODE CAPITAL MANAGEMENT, LLC previously held 0 shares of EFTR (eFFECTOR Therapeutics, Inc.) before exiting the position in 2024-Q3.

Question 2

What is GEODE CAPITAL MANAGEMENT, LLC's EFTR position worth?

Accepted Answer

GEODE CAPITAL MANAGEMENT, LLC's EFTR position was last reported at $0 in 2024-Q3 before the exit.

Question 3

Is GEODE CAPITAL MANAGEMENT, LLC buying or selling EFTR?

Accepted Answer

In 2024-Q3, GEODE CAPITAL MANAGEMENT, LLC exited their EFTR position entirely (-100.0% change in shares).

Question 4

When did GEODE CAPITAL MANAGEMENT, LLC first buy EFTR?

Accepted Answer

Based on available 13F filings, GEODE CAPITAL MANAGEMENT, LLC first reported a position in EFTR in 2021-Q3. They have held the position across 13 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$0.04	0
2024-Q2	Increased	25,583	+13.2%	$7,422	0.0%	$0.29	12
2024-Q1	Decreased	22,609	-94.5%	$325,404	0.0%	$14.39	0
2023-Q4	Increased	407,974	+54.7%	$190,733	0.0%	$11.69	22
2023-Q3	Increased	263,758	+151.2%	$158,294	0.0%	$15.00	25
2023-Q2	Unchanged	104,982	0.0%	$87,156	0.0%	$18.99	0
2023-Q1	Decreased	104,982	-1.3%	$37,783	0.0%	$8.74	0
2022-Q4	Unchanged	106,346	0.0%	$45,000	0.0%	$10.69	0
2022-Q3	Unchanged	106,346	0.0%	$60,000	0.0%	$14.25	0
2022-Q2	Unchanged	106,346	0.0%	$151,000	0.0%	$36.75	0
2022-Q1	Increased	106,346	+11.0%	$426,000	0.0%	$101.25	27
2021-Q4	Increased	95,801	+299.1%	$793,000	0.0%	$194.25	40
2021-Q3	New	24,005	-	$337,000	0.0%	$365.50	36

EFTR13 quarters

EFTR
13 quarters